Inventor · disambiguated record
Mark Parrington
Also filed as: PARRINGTON MARK
14 granted patents·7 pending applications·126 citations·filing 1997–2022
90Inventor score
Top patents by PatentIndex Score
21 records- 0187US6060308ARNA respiratory syncytial virus vaccinesCONNAUGHT LAB·Filed 1997·Granted May 9, 2000·74 cites·28 claims
- 0286US7786278B2Modified CEA nucleic acid and expression vectorsSANOFI PASTEUR LTD·Filed 2003·Granted Aug 31, 2010·18 cites·44 claims
- 0385US8207314B2Tumor antigens for prevention and/or treatment of cancerBERINSTEIN NEIL·Filed 2004·Granted Jun 26, 2012·15 cites·21 claims
- 0473US8236776B2Modified CEA nucleic acid and expression vectorsPARRINGTON MARK·Filed 2010·Granted Aug 7, 2012·1 cites·18 claims
- 0572US7851213B2Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancerSANOFI PASTEUR LTD·Filed 2003·Granted Dec 14, 2010·3 cites·32 claims
- 0668US8911991B2Multi-antigen vectors of melanomaBERINSTEIN NEIL·Filed 2004·Granted Dec 16, 2014·1 cites·1 claims
- 0766US8021664B2Tumor antigens Bfa5 for prevention and/or treatment of cancerSANOFI PASTEUR LTD·Filed 2004·Granted Sep 20, 2011·3 cites·8 claims
- 0862US2023302112A1Respiratory synctial virus rna vaccineSANOFI SA·Filed 2022·Application pending·0 cites
- 0959US8530442B2Modified CEA nucleic acid and expression vectorsPARRINGTON MARK·Filed 2012·Granted Sep 10, 2013·0 cites·10 claims
- 1056US8562970B2Modified CEA/B7 vectorPARRINGTON MARK·Filed 2004·Granted Oct 22, 2013·0 cites·12 claims
- 1155US7220826B1Expressing gp140 fragment of primary HIV-1 isolateSANOFI PASTEUR LTD·Filed 2000·Granted May 22, 2007·0 cites·2 claims
- 1254US9217158B2Replication-defective flavivirus vaccines and vaccine vectorsPUGACHEV KONSTANTIN V·Filed 2012·Granted Dec 22, 2015·0 cites·8 claims
- 1354US2009156519A1Modified KSA and Uses ThereofAVENTIS PASTEUR INC·Filed 2004·Application pending·0 cites
- 1453US8946174B2Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancerBERINSTEIN NEIL·Filed 2010·Granted Feb 3, 2015·0 cites·24 claims
- 1548US2013011422A1Tumor Antigens for the Prevention and/or Treatment of CancerBERINSTEIN NEIL·Filed 2012·Application pending·0 cites
- 1646US6428324B1RNA respiratory syncytial virus vaccinesAVENTIS PATEUR LTD·Filed 1998·Granted Aug 6, 2002·7 cites·22 claims
- 1742US6475780B1Alphavirus vectors for paramyxovirus vaccinesAVENTIS PASTEUR·Filed 1998·Granted Nov 5, 2002·4 cites·17 claims
- 1840US2005037015A1Immunogenic compositions comprising an antigen and a purified m protein from respiratory syncytial virusFiled 2002·Application pending·0 cites
- 1932US2012128713A1Replication-Defective Flavivirus Vaccine Vectors Against Respiratory Syncytial VirusPUGACHEV KONSTANTIN V·Filed 2010·Application pending·0 cites
- 2032US2017121373A1Expression and conformational analysis of engineered influenza hemagglutininSANOFI PASTEUR INC·Filed 2015·Application pending·0 cites
- 2131US2004022800A1Respiratory syncytial virus vaccineFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Parrington files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →